If you’ve injected your weight-loss medication in an airport bathroom, you’re not alone. Or maybe you decided to skip your vacation altogether to avoid the hassle. Research from Levity, a digital ...
After launching a multi-campus phased rollout of the predictive insulin dosing software, Philadelphia-based Temple Health’s University Hospital has reduced hypoglycemia rates two- to threefold. The ...
The ACR recently issued the first formal international consensus guidance statement on diagnosing and managing VEXAS syndrome.
India embraces GLP-1 medications as a major advance in diabetes and obesity care. At AajTak Health Summit, endocrinologist Dr. Ambrish Mithal and Vikrant Shrotriya, Vice President MD, Novo Nordisk ...
Medicus Pharma (MDCX) announced feedback from Type C meeting with United States Food and Drug Administration. The purpose of the Type C meeting ...
Semaglutide appears to provide a greater cardiovascular benefit vs dulaglutide in older T2D patients with ASCVD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback